SS INNOVATIONS INTERNATIONAL, INC.

SSII ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $42.5M $20.6M $5.9M $1.4M
Cost of Revenue $22.9M $12.2M $5.1M $1.4M
Gross Profit $19.5M $8.5M $725.5K $60.6K
Gross Margin 46.0% 40.9% 12.3% 4.2%
Operating Expenses
Research & Development $3.7M $2.5M $1.1M $987.4K $1.0K $3.0K $60.9K
SG&A Expense $14.8M $10.2M $10.1M $1.9M $458.8K $287.7K $752.0K
Operating Income $-8.2M $-19.0M $-20.3M $-3.0M $-1.5M $-1.1M $-3.4M
Operating Margin -19.3% -91.9% -345.1% -206.0%
Interest Expense $271.6K $317.2K $523.4K $162.0K $1.1K $19.7K
Pretax Income $-8.2M $-19.2M $-20.9M $-3.2M $-1.5M $-1.1M $-3.4M
Income Tax Expense $4.0M
Net Income $-12.1M $-19.2M $-20.9M $-3.2M $-1.5M $-1.1M $-3.4M
Net Margin -28.5% -92.7% -355.4% -223.8%
EPS (Basic) $-0.06 $-0.11 $-0.14 $-0.03 $-0.01 $-0.01 $-0.04
EPS (Diluted) $-0.06 $-0.11 $-0.14 $-0.03 $-0.01 $-0.01 $-0.04
Shares Outstanding (Basic) 200.2M 190.0M 170.8M 144.9M 128.2M 113.9M 93.5M 86.1M
Shares Outstanding (Diluted) 200.2M 198.7M 181.2M 152.1M 128.2M 113.9M 93.5M 86.1M
Dividends Per Share
← Newer Page 1 of 2 Older →